BioCentury
ARTICLE | Clinical News

CPC-111: Began Phase II trial

February 22, 1994 8:00 AM UTC

Cypros Pharmaceutical Corp. (CYPR), Carlsbad, Calif. Product: CPC-111, naturally occurring small molecule that generates adenosine triphosphate in the absence of oxygen Indication: Adult respiratory d...